Dr. MacCumber on Latest Evidence Based Retina Podcast 2026
Exciting advances in the fight against geographic atrophy (GA), a leading cause of vision loss in patients with age-related macular degeneration (AMD).
In a recent episode of Evidence Based Retina, Professor Mathew MacCumber, MD, PhD, FASRS discussed promising Phase 1 results for APL-3007, an investigational therapy designed to work alongside pegcetacoplan to target the complement pathway in GA. Early findings showed meaningful reductions in complement C3 levels with a favorable safety profile, paving the way for the ongoing Phase 2 GALLOP study.
Research like this offers hope for expanding treatment options and slowing disease progression for patients living with GA.
Learn more about this emerging approach to retinal care and the future of GA treatment. Make sure you check it out here!
